Novonesis B Unsp/Adr (NVZMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2011 | 12-2010 | |
| Sales | 492,636 | 437,528 |
| Gross Profit | 492,636 | 437,528 |
| Operating Income | 492,636 | 437,528 |
| Pre-tax Income | 492,636 | 437,528 |
| Net Income Continuous | 90,036 | 63,700 |
| Net Income | $90,036 | $63,700 |
| EPS Basic Total Ops | 0.29 | 0.20 |
| EPS Basic Continuous Ops | 0.29 | 0.20 |
| EPS Diluted Total Ops | 0.28 | 0.20 |
| EPS Diluted Continuous Ops | 0.28 | 0.20 |
| EBITDA(a) | $492,636 | $437,528 |